BRM bromodomain (1367-1511 aa) (GST-tagged), Human recombinant protein
BRM bromodomain (1367-1511 aa) (GST-tagged), Human recombinant
|Calculated MW||43.7 kDa (1367-1511 aa + NT GST Tag)|
|Other Names||SMARCA2A/B; SWI/SNF ATPase|
|Storage||-80°C; 50 mM Tris, pH 7.5, containing 500 mM sodium chloride, 5% glycerol, and 5 mM β-mercaptoethanol.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The acetylation of histone lysine residues plays a crucial role in the epigenetic regulation of gene transcription. A bromodomain is a protein domain that recognizes acetylated lysine residues such as those on the N-terminal tails of histones. This recognition is often a prerequisite for protein-histone association and chromatin remodeling. These domains function in the linking of protein complexes to acetylated nucleosomes, thereby controlling chromatin structure and gene expression. Thus, bromodomains serve as “readers” of histone acetylation marks regulating the transcription of target promoters. BRM is a member of the SWI/SNF protein family, which forms part of a large ATP-dependent chromatin remodeling complex. This complex is required for transcriptional activation of genes normally repressed by chromatin.
Muchardt C.,et al.EMBO J. 12:4279-4290(1993).
Chiba H.,et al.Nucleic Acids Res. 22:1815-1820(1994).
Humphray S.J.,et al.Nature 429:369-374(2004).
Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
Kitagawa H.,et al.Cell 113:905-917(2003).
If you have any additional inquiries please email technical services at email@example.com.